November 1, 2019 — The American Society for Radiation Oncology (ASTRO) today expressed strong support for the nomination of radiation oncologist Stephen Hahn, M.D., FASTRO, as Commissioner of the Food and Drug Administration (FDA). Hahn served on the ASTRO Board of Directors from 2014 to 2018.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now